Tender detail
Non-exclusive discount agreement for rotigotine medicines
Summary
DAK-Gesundheit intends to conclude non-exclusive medicine discount agreements with interested pharmaceutical companies for medicines containing rotigotine (ATC N04BC09). The agreement is scheduled to run from 1 January 2027 to 31 December 2028, with one optional 12-month extension, and will end earlier if an exclusive agreement takes effect.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.